Whats New in the World of Gallium-68 (Part 1)

Course overview

UAN: 0018-0000-17-205-H04-P RELEASE: 10/16/2017 EXPIRE: 10/16/2020 CREDITS: 2.25 LEARNING OBJECTIVES: 1. Describe the benefits and disadvantages of Ga-68 as an potential imaging agent 2. Review the role of Ga-68 in pre-clinical and clinical research 3. Identify the benefits of Ga-68 labeled radiopharmaceuticals for neuroendocrine and prostate cancer imaging 4. Summarize the Ge-68/Ga-68 generator licensing regulations 5. Describe the steps of eluting a GalliPharm generator and the process of measuring Ge-68 breakthrough 6. Recognize various supplies and equipment needed to elute and prepare Ga-68 dotatate 7. Summarize the differences in dispensing, delivery and cost of Ga-68 dotatate for a hospital versus a commercial nuclear pharmacy 8. Identify the differences between Ga-68 dotatate and In-111 pentetreotide NOTE: An annual subscription for Purdue’s nuclear pharmacy recertification program provides access to both the continuing education component of the program and the Radiopharmacy Portal, a reference resource for practitioners. Subscriptions to the continuing educational offerings, which have been accredited through ACPE and BPS, can be purchased for an annual fee of $195 for nuclear pharmacists and $95 for nuclear pharmacy technicians.